好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2011 Annual Meeting | Morning Report: Neurogenetics

Monday 04/23/12
06:30 AM - 08:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Morning Report
Massimo Pandolfo, MD, FAAN
Participants should be informed about the major recent advances in neurogenetics, understand and critically evaluate their impact on diagnosis and treatment of patients with common and rare neurological diseases, as well as their ethical and health policy implications.
No CME available
Patient Care & Procedural Skills, Professionalism, Medical Knowledge
Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist
Case-based, Didactic, Interactive, Audience Participation
Event Timeline
06:30 AM - 08:00 AM Neurogenetics: What Is New and How It May Affect My Practice
Massimo Pandolfo, MD, FAAN
06:30 AM - 08:00 AM Break
Faculty Disclosures
Massimo Pandolfo, MD, FAAN Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Design Therapeutics . Dr. Pandolfo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Bio. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Design Therapeutics. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Pandolfo has stock in Voyager Therapeutics. The institution of Dr. Pandolfo has received research support from Freidreich Ataxaia Research Alliance. Dr. Pandolfo has a non-compensated relationship as a Scientific Advisory Board with Friedreich Ataxia Research Alliance that is relevant to AAN interests or activities. Dr. Pandolfo has a non-compensated relationship as a Member-Meeting Management Committee with AAN that is relevant to AAN interests or activities.